From the monthly archives:
Imagenetix Also Introduces New Ear, Nose and Throat Product – BioGuard(TM) – BioGuard(TM) Promotes Protection for the Entire Family SAN DIEGO, Aug. 19 /PRNewswire-FirstCall/ — Imagenetix, Inc. (OTC Bulletin Board: IAGX – News) announced that InflameAway Celadrin® extra strength soft gels for joint health are currently available at the nation’s number one drug chain, the [...]
{ Comments on this entry are closed }
Listen to the interview below. Imagenetix, Inc. (OTC Bulletin Board: IAGX – News), an innovator of scientifically tested, natural-based, proprietary, bioceutical products developed to enhance human health, announced today that its Director of Research and Development, Dr. Robert Hesslink, discussed 1-TDC and periodontal disease on Bloomberg Radio. The company also recently announced the publication of [...]
{ Comments on this entry are closed }
SAN DIEGO, Aug. 13 /PRNewswire-FirstCall/ — On June 22, 2009, Cetyl Max/Flexadren mischaracterized certain facts associated with the settlement between those entities and Imagenetix (OTC Bulletin Board: IAGX – News). Both companies extend their apologies to Imagenetix and to those who may have been affected by the mischaracterization.
{ Comments on this entry are closed }
SAN DIEGO, Aug. 12 /PRNewswire-FirstCall/ — Imagenetix, Inc. (OTC Bulletin Board: IAGX – News), announced today the publication of a second study conducted on its proprietary compound, 1-TDC, for the treatment of periodontal disease. Dr. Hatice Hasturk, D.D.S., Ph.D. from Boston University, Department of Periodontology and Oral Biology, led the investigative team. The study was [...]
{ Comments on this entry are closed }